EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of COVID-19 Diagnosis Codes for Identification of SARS-CoV-2 Infections in a Nursing Home Cohort, 2022–2023

Arshiya Patel, Amanda B Payne, Dustin W Currie, Thomas Franceschini, Amber Gensheimer, Joseph D Lutgring, Sujan C Reddy, Kelly M Hatfield

Journal of the American Medical Directors Association · 2025

DOI: 10.1016/j.jamda.2024.105440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Medical Directors Association, 2025. Verfasst von Arshiya Patel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, …. Hauptthemen laut MEDLINE: Nursing Homes, COVID-19. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to evaluate the utility of electronic health record (EHR) diagnosis codes for monitoring SARS-CoV-2 infections among nursing home residents. DESIGN: A retrospective cohort study design was used to analyze data collected from nursing homes operating under the tradename Signature Healthcare between January 2022 and June 2023. SETTING AND PARTICIPANTS: Data from 31,136 nursing home residents across 76 facilities in Kentucky, Tennessee, Indiana, Ohio, North Carolina, Georgia, Alabama, and Virginia were included. METHODS: Resident demographics, diagnosis codes associated with clinical diagnoses (including COVID-19), and SARS-CoV-2 testing information were collected from the EHR and supplemental testing data sources. We described the rates of infection and the clinical characteristics of residents with incident-positive SARS-CoV-2 tests and new-onset COVID-19 diagnoses. Positive predictive values (PPVs) of COVID-19 diagnosis codes were calculated for residents stratified by whether a resident was continuously present in a facility for ±3 days from the diagnosis onset date listed in EHRs, using positive SARS-CoV-2 tests to confirm infection. RESULTS: A total of 4876 incident-positive SARS-CoV-2 tests and 6346 new-onset COVID-19 diagnoses were recorded during the study period. Weekly rates of new-onset diagnoses were significantly higher than positive test rates, although trends followed similar trajectories. Among residents continuously present in the nursing home ±3 days from the diagnosis onset date, the PPV of COVID-19 diagnosis codes was high (3395 of 3685 = 92%; 95% CI, 91%-93%). The PPV among this group significantly varied by study quarter (P < .001). The PPV was substantially lower for 2661 diagnoses among residents not continuously present in the nursing home (24%; 95% CI, 22%-26%). CONCLUSIONS AND IMPLICATIONS: This study demonstrates the utility of diagnosis codes for assessment of COVID-19 epidemiology and trends when testing data are unavailable for residents during their stay in a nursing home. Future research should explore strategies to evaluate the utility of diagnosis codes at admission and discharge to nursing homes to enhance surveillance efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nursing HomesCOVID-19HumansRetrospective StudiesMaleFemaleAgedAged, 80 and overElectronic Health RecordsSARS-CoV-2COVID-19 TestingUnited States

Stichwörter der Autor:innen

COVID-19ICD-10SARS-CoV-2electronic health recordnursing homerespiratory infections

Autor:innen und Institutionen

  • Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Professional Services Business Unit, Chenega Enterpr…
  • Coronavirus and Other Respiratory Viruses Division, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Signature Healthcare, Louisville, KY, USA.

Förderung

  • Intramural CDC HHS

Zitieren

APA

Patel, A., Payne, A. B., Currie, D. W., Franceschini, T., Gensheimer, A., Lutgring, J. D., Reddy, S. C., & Hatfield, K. M. (2025). Evaluation of COVID-19 Diagnosis Codes for Identification of SARS-CoV-2 Infections in a Nursing Home Cohort, 2022–2023. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2024.105440

Vancouver

Patel A, Payne AB, Currie DW, Franceschini T, Gensheimer A, Lutgring JD, et al. Evaluation of COVID-19 Diagnosis Codes for Identification of SARS-CoV-2 Infections in a Nursing Home Cohort, 2022–2023. Journal of the American Medical Directors Association. 2025. doi:10.1016/j.jamda.2024.105440

BibTeX
@article{Patel2025,
  author = {Patel, Arshiya and Payne, Amanda B and Currie, Dustin W and Franceschini, Thomas and Gensheimer, Amber and Lutgring, Joseph D and Reddy, Sujan C and Hatfield, Kelly M},
  title = {Evaluation of COVID-19 Diagnosis Codes for Identification of SARS-CoV-2 Infections in a Nursing Home Cohort, 2022–2023},
  journal = {Journal of the American Medical Directors Association},
  year = {2025},
  doi = {10.1016/j.jamda.2024.105440}
}
Kostenlos starten →